videos
-
.
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. . .
-
.
.
.
.then, corinna and tobias found out that she was pregnant again -- with twin boys. doctors confirmed that the twins carried the affected gene.
$17
OFF DEAL
OFF DEAL
GET DEAL
218 Used Today
50%
OFF DEAL
OFF DEAL
$20
OFF DEAL
OFF DEAL
GET DEAL
200 Used Today